Treatment of Gastroesophageal Reflux Disease in Infants
NCT06255886
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Gastroesophageal Reflux
Infant, Newborn, Diseases
Interventions
DRUG:
Protein pump inhibitor.
BEHAVIORAL:
Mother or infant diet
DRUG:
Placebo
Sponsor
Odense University Hospital